Related Experiment Video
Updated: May 9, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression
Jie Yin1, Jianmin Ding, Li Huang
1Department of Immunology and Biochemistry, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China; Tianjin Key Laboratory of Cellular and Molecular Immunology, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China; Key laboratory of Educational Ministry of China, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China; Laboratory of Molecular Immunology, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China.
Abstract:
Staphylococcal nuclease domain containing 1 (SND1) is a ubiquitously expressed multifunctional protein involved in transcriptional regulation, RNA splicing and RNA metabolism. Ectopic expression of SND1 has been observed in various tumors including colon cancer, breast cancer, prostate cancer and hepatocellular carcinoma (HCC), indicating a positive role of SND1 in tumor initiation and progression. However, the exact role of SND1 in cancers has not been thoroughly investigated. In the present study, we investigated the role of SND1 in HCC. Immunohistochemistry analysis revealed that the expression level of SND1 was higher in HCC tissues than in adjacent nontumor tissues. Stable knock-down of SND1, performed on the HCC cell line SMMC-7721 using shRNA lentiviral expression system, led to reduced cell proliferation, clone formation and tumor formation in nude mice. The insulin-like growth factor (IGF) signaling pathway was frequently dysregulated in HCC, which could facilitate tumor progression. Screening of gene expression levels of the IGF pathway, using real-time PCR, revealed that a decrease in SND1 expression could increase the expression of IGF-binding protein 3 (IGFBP3), which can negatively regulate activation of the IGF pathway by restricting interactions between IGF and IGF receptors. Results from previous studies showed that the downregulation of IGFBP3 expression is a common feature in HCC, and the upregulation of IGFBP3 expression could suppress HCC cells proliferation. We further confirmed that stable knock-down of IGFBP3 could promote SMMC-7721 cells proliferation. Therefore, we concluded that SND1 could affect SMMC-7721 cells proliferation by regulating IGFBP3 expression and IGF signaling pathway.
Insights
Staphylococcal nuclease domain containing 1 (SND1) promotes hepatocellular carcinoma (HCC) by downregulating IGFBP3 and activating IGF signaling. Reducing SND1 inhibits HCC cell proliferation and tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Staphylococcal nuclease domain containing 1 (SND1) is a multifunctional protein implicated in various cancers.
- Its specific role in hepatocellular carcinoma (HCC) progression remains largely uninvestigated.
- Ectopic SND1 expression is observed in multiple tumor types, suggesting oncogenic potential.
Purpose of the Study:
- To elucidate the role of SND1 in hepatocellular carcinoma (HCC) progression.
- To investigate the molecular mechanisms by which SND1 influences HCC cell behavior.
- To determine the relationship between SND1, IGFBP3, and the insulin-like growth factor (IGF) signaling pathway in HCC.
Main Methods:
- Immunohistochemistry was used to compare SND1 expression in HCC and adjacent non-tumor tissues.
- Stable knockdown of SND1 in HCC cell line SMMC-7721 was achieved using shRNA lentiviral vectors.
- Cell proliferation, clone formation, and tumor formation in nude mice were assessed.
- Real-time PCR was employed to analyze gene expression within the IGF signaling pathway.
- Knockdown of IGFBP3 was performed to evaluate its effect on HCC cell proliferation.
Main Results:
- SND1 expression was significantly higher in HCC tissues compared to adjacent non-tumor tissues.
- SND1 knockdown reduced HCC cell proliferation, colony formation, and tumor growth in vivo.
- Decreased SND1 expression led to increased IGF-binding protein 3 (IGFBP3) expression.
- IGFBP3 knockdown promoted HCC cell proliferation, confirming its tumor-suppressive role.
- SND1 appears to regulate HCC progression by modulating IGFBP3 expression and IGF signaling.
Conclusions:
- SND1 plays a crucial role in promoting HCC initiation and progression.
- SND1 exerts its oncogenic effects by downregulating IGFBP3 expression, thereby activating the IGF signaling pathway.
- Targeting SND1 may represent a potential therapeutic strategy for hepatocellular carcinoma.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
Hedgehog Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...